2023
DOI: 10.1016/j.ejpb.2023.01.023
|View full text |Cite
|
Sign up to set email alerts
|

Seborrheic dermatitis: topical therapeutics and formulation design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 119 publications
0
9
0
Order By: Relevance
“…It has long been known that seasonal variations and geographical differences may influence the lipid content of the skin. 17,38 With or without inflammation, the lipophilic Malassezia genus plays a key role in their pathogenesis, and reduction of these yeasts on the scalp is one of the main therapeutic targets. 3,4,31,37 KTZ, CLZ, and PRT are common agents that are active against TA B L E 1 Studied formulations and their properties.…”
Section: Discussionmentioning
confidence: 99%
“…It has long been known that seasonal variations and geographical differences may influence the lipid content of the skin. 17,38 With or without inflammation, the lipophilic Malassezia genus plays a key role in their pathogenesis, and reduction of these yeasts on the scalp is one of the main therapeutic targets. 3,4,31,37 KTZ, CLZ, and PRT are common agents that are active against TA B L E 1 Studied formulations and their properties.…”
Section: Discussionmentioning
confidence: 99%
“…Barrier impairment parallels that of atopic dermatitis where emollients are used effectively 69 . Treating SD by improving the skin barrier function has been proposed as a potential adjuvant therapy, 70 but the management of SD remains focussed on anti‐inflammatory and anti‐fungal treatments 71 . Taken together, the incorporation of emollients, humectants or other barrier repair agents should not be neglected in the management of SD and might support current treatment modalities.…”
Section: Discussionmentioning
confidence: 99%
“…Barrier impairment parallels that of atopic dermatitis where emollients are used effectively. 69 Treating SD by improving the skin barrier function has been proposed as a potential adjuvant therapy, 70 but the management of SD remains focussed on anti-inflammatory and anti-fungal treatments. 71…”
Section: Con Clus Ionmentioning
confidence: 99%
“…These cosmetics are in the form of a cream, lotion, body milk, or occasionally even as fluid for normal, dry, or oily skin. [1][2][3] Emulsions are typically used as cosmetic formulations due to their high ability of skin penetration, easy wash off, and variable viscosity. 4 Various pharmaceutical preparations used in the management of chronic skin diseases are formulated as emulsion systems.…”
Section: Introductionmentioning
confidence: 99%
“…The bases for skincare formulations for both healthy and diseased skin are a variety of cosmetic emulsions. These cosmetics are in the form of a cream, lotion, body milk, or occasionally even as fluid for normal, dry, or oily skin 1–3 . Emulsions are typically used as cosmetic formulations due to their high ability of skin penetration, easy wash off, and variable viscosity 4 .…”
Section: Introductionmentioning
confidence: 99%